Reference Pricing in US Government COVID-19-related Contracts

Knowledge Ecology International conducted a review of contracts entered into by the US government concerning COVID-19-related treatments, diagnostics, vaccines, and other countermeasure-related technologies, regarding reference pricing clauses in the agreements. Of the 104 contracts reviewed, it is difficult to say… Continue Reading

Media coverage of the WHO pandemic treaty negotiations (on transparency and content) – First quarter, 2023

Media coverage of the WHO pandemic treaty negotiations (on transparency and content) – March/April 2023 2 February 2023, Reuters, Draft WHO pandemic deal pushes for equity to avoid COVID ‘failure’ repeat, By Jennifer Rigby and Gabrielle Tétrault-Farber. However, there will… Continue Reading

Thursday webinar on Bayh-Dole safeguards including Xtandi march in and government use petition, and federal government review of march in rights

(UPDATE: A recording of the event is available on our YouTube channel here: https://www.youtube.com/watch?v=_qFgm-dohuU) Date: Thursday April 20, 2023 Time: 1:30 PM to 3:00 PM EDT Knowledge Ecology International is hosting an online discussion of two Bayh-Dole safeguard related topics.… Continue Reading

KEI Comments to NIH Regarding Prospective Exclusive License to Oncala Bio for Cancer Treatment

On April 12, 2023, Knowledge Ecology International submitted comments to the National Institutes of Health (NIH) regarding the “Prospective Grant of an Exclusive Patent License: Development and Commercialization of Metarrestin and Its Analogs for the Treatment of Metastatic Cancers” (88… Continue Reading

Cancer patients file administrative appeal on NIH rejection of Xtandi march-in petition with Secretary of HHS Becerra

On March 23, 2023, three prostate cancer patients, Robert Sachs, Clare Love and Eric Sawyer, filed an administrative appeal of the NIH decision to reject petition that HHS use Federal rights in patents on Xtandi to address pricing discrimination against… Continue Reading

KEI Comments to the NIH on Prospective Exclusive License to BrickBio Treatment for Solid Tumors

On March 20, 2023, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) regarding the “Prospective Grant of an Exclusive Patent License: The Development of a CD276 Antibody-Drug Conjugate (ADC) for the Treatment of Solid Tumors”… Continue Reading

INB4: KEI general comment on the Zero Draft

On 28 February 2023, Knowledge Ecology International (KEI) delivered the following statement on the zero draft prepared by the Bureau of the Intergovernmental Negotiating Body to draft and negotiate a WHO convention, agreement or other international instrument on pandemic prevention,… Continue Reading

US government files statement of Interest in Arbutus v Moderna case, testing scope of 28 USC 1498(a) government use of patents for acquisition and distribution of COVID 19 vaccines

On February 14, 2023, USDOJ filed a Statement of Interest of the United States, in the patent dispute between Arbutus Biopharma, Genevant Sciences, and Moderna. A copy of the filing is here: arbutus.moderna.USG.statementofinterest This is an important, and while not… Continue Reading

WHO pandemic treaty: Modalities for the negotiations in February/March 2023 (INB4) and April 2023 (INB5)

UPDATED: On 10 February 2023, the Bureau of the WHO Intergovernmental Negotiating Body (INB) circulated to WHO member states a proposal for consideration by the INB regarding modalities for upcoming INB meetings (INB4/5), including the “Zero Draft” and “First Draft”… Continue Reading